Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis Inc. is set to experience substantial revenue growth, with projections indicating an increase to $43 million in systems revenue and $31 million in disposable revenue by FY26, driven by the adoption of new systems and catheter utilization. The company reported a remarkable revenue of $8.8 million in the second quarter, marking a year-over-year increase of 95% and a sequential rise of 18%, indicating strong market traction. Additionally, Stereotaxis's successful regulatory advancements and ongoing product launches, particularly the MAGiC and MAGiC Sweep catheters, position the company for further leverage and increased revenue streams, with expectations for quarterly earnings to exceed $10 million in FY26.

Bears say

Stereotaxis Inc. reported operating expenses of $8.6 million, with adjusted expenses decreasing to $6 million, but still indicates significant cost pressures amid challenges in their operating environment. The company faces multiple risks, including delays in product approvals, supply chain issues, and increased competition, all of which could adversely affect revenue streams and impede growth. Additionally, Stereotaxis has a limited cash runway of two years, necessitating further financing, and is vulnerable to reimbursement rate reductions that may negatively impact its financial performance.

Stereotaxis Inc (STXS) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 2 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Mar 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.